Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples